BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37699683)

  • 1. [Digital cell models and their applications: a review].
    Yuan Q; Mao Z; Yang X; Liao X; Ma H
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4146-4161. PubMed ID: 37699683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthetic biology: from "build-for-use" to commercialization].
    Zhao G
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4001-4011. PubMed ID: 37699671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling technology and core theory of synthetic biology.
    Zhang XE; Liu C; Dai J; Yuan Y; Gao C; Feng Y; Wu B; Wei P; You C; Wang X; Si T
    Sci China Life Sci; 2023 Aug; 66(8):1742-1785. PubMed ID: 36753021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development path of industrial biotechnology in Chinese Academy of Sciences].
    Yang M; Zhou J
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4027-4034. PubMed ID: 37699674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rational design and applications of industrial proteins].
    Qu G; Yuan B; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4068-4080. PubMed ID: 37699678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preface to the special issue on the 10th anniversary of Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences].
    Wang Q; Ma Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):3981-3990. PubMed ID: 37699669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in automated high-throughput editing and screening of engineered strains].
    Tu R; Mao Y; Liu Y; Cheng H; Yuan W; Yu S; Pan W; An J; Wang M
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4162-4179. PubMed ID: 37699684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic biology advances and applications in the biotechnology industry: a perspective.
    Katz L; Chen YY; Gonzalez R; Peterson TC; Zhao H; Baltz RH
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):449-461. PubMed ID: 29915997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Active promotion of bio-industry technology development in China].
    George FG
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4012-4018. PubMed ID: 37699672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green systems biology - From single genomes, proteomes and metabolomes to ecosystems research and biotechnology.
    Weckwerth W
    J Proteomics; 2011 Dec; 75(1):284-305. PubMed ID: 21802534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Developments of core technologies in industrial enzymes and green bioprocessing].
    Zheng H; Xu J; Yang J; Zheng Y; Tu R; Shi T; Fu G; Liu Q; Wang X; Han X; Zhang Y; Bai W; Song H
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4219-4239. PubMed ID: 37699687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opportunities and challenges for fermentation optimization and scale-up technology in the artificial intelligence era].
    Xia J; Liu J; Zhuang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4180-4199. PubMed ID: 37699685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in gene editing technologies for Saccharomyces cerevisiae].
    Li H; Liang X; Zhou J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):950-965. PubMed ID: 33783160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-scale metabolic network models: from first-generation to next-generation.
    Ye C; Wei X; Shi T; Sun X; Xu N; Gao C; Zou W
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):4907-4920. PubMed ID: 35829788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-scale metabolic network models for industrial microorganisms metabolic engineering: Current advances and future prospects.
    Gong Z; Chen J; Jiao X; Gong H; Pan D; Liu L; Zhang Y; Tan T
    Biotechnol Adv; 2024; 72():108319. PubMed ID: 38280495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thirty years development of metabolic engineering: a review].
    Chen T; Cui Z; Hu W; Wang Z; Zhao X
    Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1477-1493. PubMed ID: 34085438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering microalgae: transition from empirical design to programmable cells.
    Lu Y; Zhang X; Gu X; Lin H; Melis A
    Crit Rev Biotechnol; 2021 Dec; 41(8):1233-1256. PubMed ID: 34130561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.